Diuretics on Par in Head-to-Head Comparison for Hypertension
(MedPage Today) -- Chlorthalidone didn't best hydrochlorothiazide (HCTZ) for reducing cardiovascular risk in the treatment of hypertension, a pragmatic VA trial showed.
For the primary outcome of major adverse cardiovascular events and non-cancer...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Hydrochlorothiazide | Hypertension | Urology & Nephrology